| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 07/07/2009 | US7557182 Drug delivery across the blood-brain barrier using polypeptides; neurological diseases; aprotinin |
| 07/07/2009 | US7557137 Gamma-lactams as beta-secretase inhibitors |
| 07/07/2009 | US7557078 Morphogen-induced nerve regeneration and repair |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/02/2009 | WO2009081152A2 Antimicrobial compounds |
| 07/02/2009 | US20090170792 Peptide ligands |
| 07/02/2009 | US20090170785 Peptide substance revealing an immunogeroprotective effect, pharmaceutical composition on its base and the method of its application |
| 07/02/2009 | US20090170784 Crystalline and amorphous forms of peptide |
| 07/02/2009 | US20090170783 Novel tetrahydrocarbazole derivatives as ligands of g-protein coupled receptors |
| 07/02/2009 | US20090169510 treating hepatitis by modulating NS3/NS4 protease comprising contacting a NS3/NS4 protease with a compound of the invention |
| 07/02/2009 | CA2709884A1 Antimicrobial compounds |
| 07/01/2009 | EP2074136A2 Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| 07/01/2009 | EP1673633B1 Method for detecting feline immunodeficiency virus |
| 07/01/2009 | EP1301486B1 Imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 07/01/2009 | EP1104310B1 Expression and characterization of hiv-1 envelope protein associated with a broadly reactive neutralizing antibody response |
| 07/01/2009 | CN100507563C N.epsilon. and/or n.alpha. derivatized, metal and organic protected l-histidine for coupling to biomolecules for highly efficient labeling with [m(oh2)3(co)3]+ by fac coordination |
| 07/01/2009 | CN100506981C Protein hydrolysates enriched in peptides having a carboxy terminal proline residue |
| 07/01/2009 | CN100506841C Method and carrier complexes for delivering molecules to cells |
| 06/30/2009 | US7553969 Substituted phenethylamine derivatives |
| 06/30/2009 | US7553927 Which direct localization of polynucleotides; nucleic acid of given sequence that hybridizes with probe; modifies photosynthesis and synthesis of fatty acids, amino acids, oils, carotenoids and starch |
| 06/30/2009 | US7553816 p-amidobenzylethers in drug delivery agents |
| 06/30/2009 | US7553812 Acyclovir-peptide analogs |
| 06/30/2009 | US7553617 Fusion proteins of bacteriophage coat proteins, and bacteriophage particles are screened against receptors |
| 06/25/2009 | WO2009042668A3 Urea-containing peptides as inhibitors of viral replication |
| 06/25/2009 | WO2009010733A3 Peptide gap junction modulators |
| 06/25/2009 | WO2008152306A3 Novel peptidase substrates |
| 06/25/2009 | US20090163844 Methods for the treatment or prevention of scars and/or keloids |
| 06/25/2009 | US20090163426 Prostate specific antigen; immobilization; antiproliferative agents; drug delivery; contain cleavage sites specifically cleaved by prostate specific membrane antigen (PSMA); useful for substantially inhibiting the non-specific toxicity of a variety of therapeutic drugs |
| 06/25/2009 | US20090163425 Peptide Inhibiting Angiotensin Converting Enzyme |
| 06/25/2009 | US20090162369 Synthetic chimeric peptides |
| 06/24/2009 | EP2072524A2 Anti-inflammatory peptides |
| 06/24/2009 | EP1737881B1 Novel compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 06/24/2009 | CN101466728A HCV inhibitors comprising beta amino acids and their uses |
| 06/24/2009 | CN101466727A Hcv/hiv inhibitor and their uses |
| 06/24/2009 | CN101463075A Preparation of N(2)-L-alanyl-L-glutamine |
| 06/24/2009 | CN101463074A Method for synthesizing cell toxic alkaloid and epimer thereof |
| 06/24/2009 | CN100503633C Acetes chinensis protein antigypertensive peptide and preparation method and application thereof |
| 06/24/2009 | CN100503568C Process for the preparation of perindopril, its analgous compounds and salts therof using 2,5 dioxo-oxazolidine intermediate compounds |
| 06/23/2009 | US7550568 Monoclonal antibodies to human high molecular weight-melanoma associated antigen |
| 06/23/2009 | US7550560 Deprotecting amino acid linked to solid phase resin by admixing with solution in transparent vessel while irradiating with microwaves, coupling/activating/hybridizing amino acids, then cleaving |
| 06/23/2009 | US7550559 Can also be used for HIV, (AIDS, Acquired Immune Deficiency Syndrome), and related disorders |
| 06/23/2009 | US7550431 Spatially-defined macrocycles incorporating peptide bond surrogates |
| 06/18/2009 | US20090156785 Produced from Chromobacterium cultures; depsipeptides; immunosuppressants; for treatment of graft-versus-host disease |
| 06/18/2009 | US20090156624 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 06/18/2009 | US20090156509 Tri-peptide Inhibitors of Serine Elastases |
| 06/18/2009 | US20090156508 Synthetic peptide amides and dimeric forms thereof |
| 06/18/2009 | US20090156505 Self-assembly and mineralization of peptide-amphiphile nanofibers |
| 06/18/2009 | US20090155440 Salt Enhancing Compounds and Use |
| 06/18/2009 | US20090155376 Protein hydrolysate with antidiabetic effect |
| 06/18/2009 | US20090155347 Cosmetic Composition for Stimulating the Synthesis of Proteins of the Basement Membrane |
| 06/18/2009 | US20090155304 Modified Cyanovirin-N Polypeptide |
| 06/18/2009 | US20090155289 Furin-cleavable peptide linkers for drug-ligand conjugates |
| 06/18/2009 | DE102005009784B4 Peptid-Mimetika, Verfahren zur deren Herstellung, diese enthaltende pharmazeutische Zusammensetzung und deren Verwendung als Inhibitoren von Proteasomen und zur Induktion von Apoptose Peptide mimetics, methods for their preparation, pharmaceutical composition containing them and their use as inhibitors of proteasomes and inducing apoptosis |
| 06/17/2009 | EP2071036A2 Methods for identifying RNA-binding compounds |
| 06/17/2009 | EP2070944A1 Specific binding agents of human angiopoietin-2 |
| 06/17/2009 | EP1735345B1 Processes for preparing eptifibatide and pertinent intermediate compounds |
| 06/17/2009 | CN100500691C Peptide-like endothelin receptor antagonist with proline or cyclic amino acid on 2-postion |
| 06/17/2009 | CN100500654C Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 06/16/2009 | US7547274 Radioactive member and method of making |
| 06/11/2009 | WO2009073168A1 Inhibitors of antigen presentation by mhc class ii molecules and methods of use thereof |
| 06/11/2009 | WO2009071957A2 Novel peptides and amino acid derivatives, pharmaceutical compositions containing same and the use of these compounds |
| 06/11/2009 | WO2009071601A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 06/11/2009 | WO2002099058A3 KCNMAs AS MODIFIERS OF THE p53 PATHWAY AND METHODS OF USE |
| 06/11/2009 | US20090149630 Stabilized Alpha Helical Peptides and Uses Thereof |
| 06/11/2009 | US20090149540 Compositions and Methods for Attenuating Mitochondria-Mediated Cell Injury |
| 06/11/2009 | US20090149401 Amide and peptide derivatives of tetraalkylenepentamines as transfection agents |
| 06/11/2009 | US20090148921 Compositions and methods for enhancing apoptosis |
| 06/11/2009 | US20090148407 Novel Macrocyclic Inhibitors of Hepatitis C Virus Replication |
| 06/11/2009 | US20090148382 Technetium- and rhenium-bis(heteroaryl) complexes, and methods of use thereof |
| 06/11/2009 | CA2707549A1 Boropeptide inhibitors of enteropeptidase and their uses in treatment of obesity, overweight and/or diseases associated with an abnormal fat metabolism |
| 06/10/2009 | EP2066688A2 Macrocyclic hcv inhibitors and their uses |
| 06/10/2009 | CN101454338A N-oxides of kappa opioid receptor peptides |
| 06/10/2009 | CN101454337A Aminothiazole derivatives and their uses as antibacterial agents |
| 06/10/2009 | CN100497374C N-formyl peptide receptor complex with a G-protein kinase signal pathway modification agent |
| 06/10/2009 | CN100497372C Amidomethyl substituted 1-(carboxyalkyl)-cyclopentylcarbonylamino-benzazepine-N-acetic acid derivatives, process and intermediate products for their preparation and medicaments containing these compou |
| 06/10/2009 | CN100497370C Bursopoietin extracting method and its use in disease treating and immune |
| 06/09/2009 | US7544798 Halogenation and sulfonation of a 4-hydroxy-quinolone, ring closing metathesis with 2nd generation Hoveyda's catalyst of 2-(2-(cyclopropyl-2-propenyl)aminocarbonyl)-4-hydroxy-5-alkenoyl) pyrrolidine, etherification with the quinolone; one pot process; Hepatitis C viricides |
| 06/09/2009 | US7544774 Mimotopes and anti-mimotopes of human platelet glycoprotein Ib/IX |
| 06/09/2009 | US7544773 Antimicrobials against pathogenic bacteria and method for screening them |
| 06/09/2009 | US7544768 Peptides for inducing apoptosis in tumor cells |
| 06/09/2009 | US7544365 TRPV1+ sensory neurons control of β-cells stress and islet inflammation in diabetes |
| 06/09/2009 | CA2162900C New peptide derivatives |
| 06/04/2009 | WO2009070692A1 C5-substituted, proline-derived, macrocyclic hepatitis c serine protease inhibitors |
| 06/04/2009 | WO2009070689A1 Bicyclic, c5-substituted proline derivatives as inhibitors of the hepatitis c virus ns3 protease |
| 06/04/2009 | WO2009070631A2 Ethoid compounds for use as food additives |
| 06/04/2009 | WO2009068351A2 Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k |
| 06/04/2009 | US20090143312 Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease |
| 06/04/2009 | US20090143248 Biologically active C-terminal arginine-containing peptides |
| 06/04/2009 | US20090142299 Macrocyclic tetrazolyl hepatitis c serine protease inhibitors |
| 06/04/2009 | US20090142280 Protective skin care peptides |
| 06/04/2009 | CA2707506A1 Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k |
| 06/03/2009 | EP2065366A2 HIF hydroxylase inhibitors |
| 06/03/2009 | EP2065029A1 Personal care and cosmetic composition containing tetrapeptides with the motifs GX1X2G, PX1X2P, or PX1X2K |
| 06/03/2009 | EP2064228A2 Synthetic peptide amides |
| 06/03/2009 | EP1682546B1 Peptidomimetic compounds, stereoselective process for their preparation, their use as biologically active synthetic intermediates |
| 06/03/2009 | EP1620456A4 Hla-a2 tumor associated antigen peptides and compositions |
| 06/03/2009 | EP1218544B1 TAR RNA binding peptides |
| 06/03/2009 | CN101448850A Immunomodulating oligopeptides |
| 06/03/2009 | CN101445550A Synthetic method of pyroglutamyl small peptide |
| 06/03/2009 | CA2613075A1 Synthetic antigen mimetics immuno-reactive with rheumatoid arthritis auto-antibodies |